{"downloaded": false, "htmlmade": false, "full": {"id": "26788404", "source": "MED", "pmid": "26788404", "pmcid": "PMC4691638", "fullTextIdList": {"fullTextId": "PMC4691638"}, "doi": "10.1155/2015/973298", "title": "Association of a BACE1 Gene Polymorphism with Parkinson's Disease in a Norwegian Population.", "authorString": "Lange J, Lunde KA, Sletten C, M\u00f8ller SG, Tysnes OB, Alves G, Larsen JP, Maple-Gr\u00f8dem J.", "authorList": {"author": [{"fullName": "Lange J", "firstName": "Johannes", "lastName": "Lange", "initials": "J", "authorId": {"@type": "ORCID", "#text": "0000-0003-0604-4891"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "The Norwegian Centre for Movement Disorders, Stavanger University Hospital, 4011 Stavanger, Norway."}}}, {"fullName": "Lunde KA", "firstName": "Kristin Aaser", "lastName": "Lunde", "initials": "KA", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "The Norwegian Centre for Movement Disorders, Stavanger University Hospital, 4011 Stavanger, Norway; Centre for Organelle Research, University of Stavanger, 4036 Stavanger, Norway."}}}, {"fullName": "Sletten C", "firstName": "Camilla", "lastName": "Sletten", "initials": "C", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Centre for Organelle Research, University of Stavanger, 4036 Stavanger, Norway."}}}, {"fullName": "M\u00f8ller SG", "firstName": "Simon Geir", "lastName": "M\u00f8ller", "initials": "SG", "authorId": {"@type": "ORCID", "#text": "0000-0002-0460-3592"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Biological Sciences, St. John's University, New York, NY 11439, USA."}}}, {"fullName": "Tysnes OB", "firstName": "Ole-Bj\u00f8rn", "lastName": "Tysnes", "initials": "OB", "authorId": {"@type": "ORCID", "#text": "0000-0002-7230-6426"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Neurology, Haukeland University Hospital, 5021 Bergen, Norway; Institute for Clinical Medicine, University of Bergen, 5021 Bergen, Norway."}}}, {"fullName": "Alves G", "firstName": "Guido", "lastName": "Alves", "initials": "G", "authorId": {"@type": "ORCID", "#text": "0000-0003-0630-2870"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "The Norwegian Centre for Movement Disorders, Stavanger University Hospital, 4011 Stavanger, Norway; Department of Neurology, Stavanger University Hospital, 4011 Stavanger, Norway."}}}, {"fullName": "Larsen JP", "firstName": "Jan Petter", "lastName": "Larsen", "initials": "JP", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "The Norwegian Centre for Movement Disorders, Stavanger University Hospital, 4011 Stavanger, Norway."}}}, {"fullName": "Maple-Gr\u00f8dem J", "firstName": "Jodi", "lastName": "Maple-Gr\u00f8dem", "initials": "J", "authorId": {"@type": "ORCID", "#text": "0000-0001-7142-0078"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "The Norwegian Centre for Movement Disorders, Stavanger University Hospital, 4011 Stavanger, Norway; Centre for Organelle Research, University of Stavanger, 4036 Stavanger, Norway."}}}]}, "authorIdList": {"authorId": [{"@type": "ORCID", "#text": "0000-0001-7142-0078"}, {"@type": "ORCID", "#text": "0000-0002-0460-3592"}, {"@type": "ORCID", "#text": "0000-0002-7230-6426"}, {"@type": "ORCID", "#text": "0000-0003-0604-4891"}, {"@type": "ORCID", "#text": "0000-0003-0630-2870"}]}, "dataLinksTagsList": {"dataLinkstag": ["supporting_data", "altmetrics"]}, "journalInfo": {"volume": "2015", "journalIssueId": "2263860", "dateOfPublication": "2015", "monthOfPublication": "0", "yearOfPublication": "2015", "printPublicationDate": "2015-01-01", "journal": {"title": "Parkinson's disease", "ISOAbbreviation": "Parkinsons Dis", "medlineAbbreviation": "Parkinsons Dis", "NLMid": "101539877", "ISSN": "2090-8083", "ESSN": "2042-0080"}}, "pubYear": "2015", "pageInfo": "973298", "abstractText": "Background. Parkinson's disease (PD) and Alzheimer's disease (AD) share pathological features, including amyloid-beta pathology. Amyloid-beta peptide is generated by sequential proteolysis of amyloid precursor protein (APP), and genetic variations in the processing pathway genes have been found to increase the risk of AD; however, the contribution in PD is unknown. Methods. The aim of this study was to investigate whether candidate polymorphisms in five genes (ADAM10, BACE1, BACE2, PSEN2, and CLU) involved in the APP processing pathway affect PD risk in a population-based cohort of patients with incident PD and control subjects from the Norwegian ParkWest study. Results. We found an association of rs638405 in BACE1 with increased risk of PD, thus providing a novel link, at the genetic level, between amyloid-beta pathology and PD.", "affiliation": "The Norwegian Centre for Movement Disorders, Stavanger University Hospital, 4011 Stavanger, Norway.", "publicationStatus": "ppublish", "language": "eng", "pubModel": "Print-Electronic", "pubTypeList": {"pubType": ["research-article", "Journal Article"]}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.1155/2015/973298"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC4691638"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC4691638?pdf=render"}]}, "isOpenAccess": "Y", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "Y", "citedByCount": "1", "hasData": "Y", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "license": "cc by", "authMan": "N", "epmcAuthMan": "N", "nihAuthMan": "N", "hasTMAccessionNumbers": "Y", "tmAccessionTypeList": {"accessionType": "refsnp"}, "dateOfCompletion": "2016-01-20", "dateOfCreation": "2016-01-21", "firstIndexDate": "2016-01-21", "fullTextReceivedDate": "2020-07-11", "dateOfRevision": "2020-09-28", "electronicPublicationDate": "2015-12-14", "firstPublicationDate": "2015-12-14"}, "htmllinks": "https://europepmc.org/articles/PMC4691638", "abstract": "Background. Parkinson's disease (PD) and Alzheimer's disease (AD) share pathological features, including amyloid-beta pathology. Amyloid-beta peptide is generated by sequential proteolysis of amyloid precursor protein (APP), and genetic variations in the processing pathway genes have been found to increase the risk of AD; however, the contribution in PD is unknown. Methods. The aim of this study was to investigate whether candidate polymorphisms in five genes (ADAM10, BACE1, BACE2, PSEN2, and CLU) involved in the APP processing pathway affect PD risk in a population-based cohort of patients with incident PD and control subjects from the Norwegian ParkWest study. Results. We found an association of rs638405 in BACE1 with increased risk of PD, thus providing a novel link, at the genetic level, between amyloid-beta pathology and PD.", "pdflinks": "https://europepmc.org/articles/PMC4691638?pdf=render", "journaltitle": "Parkinson's disease", "authorinfo": ["Lange J", "Lunde KA", "Sletten C", "M\u00f8ller SG", "Tysnes OB", "Alves G", "Larsen JP", "Maple-Gr\u00f8dem J"], "title": "Association of a BACE1 Gene Polymorphism with Parkinson's Disease in a Norwegian Population."}